ZA201408058B - Compositions and methods for the treatment of epilepsy - Google Patents
Compositions and methods for the treatment of epilepsyInfo
- Publication number
- ZA201408058B ZA201408058B ZA2014/08058A ZA201408058A ZA201408058B ZA 201408058 B ZA201408058 B ZA 201408058B ZA 2014/08058 A ZA2014/08058 A ZA 2014/08058A ZA 201408058 A ZA201408058 A ZA 201408058A ZA 201408058 B ZA201408058 B ZA 201408058B
- Authority
- ZA
- South Africa
- Prior art keywords
- epilepsy
- compositions
- treatment
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1791CH2012 | 2012-05-08 | ||
PCT/IB2013/050740 WO2013167986A2 (en) | 2012-05-08 | 2013-01-29 | Compositions and methods for the treatment of epilepsy |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201408058B true ZA201408058B (en) | 2016-03-30 |
Family
ID=54187089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2014/08058A ZA201408058B (en) | 2012-05-08 | 2014-11-04 | Compositions and methods for the treatment of epilepsy |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2846795A2 (en) |
JP (1) | JP2015526385A (en) |
AU (1) | AU2013257707A1 (en) |
CA (1) | CA2873016A1 (en) |
SG (1) | SG11201407309XA (en) |
WO (1) | WO2013167986A2 (en) |
ZA (1) | ZA201408058B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104379589A (en) * | 2012-05-07 | 2015-02-25 | 塞利克斯比奥私人有限公司 | Prodrugs of anti-platelet agents |
EP2870130A4 (en) * | 2012-07-03 | 2015-12-02 | Cellix Bio Private Ltd | Compositions and methods for the treatment of moderate to severe pain |
WO2015184542A1 (en) * | 2014-06-02 | 2015-12-10 | Ketogen Inc. | Compounds for the treatment of seizures and other central nervous system disorders and conditions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1092959C (en) * | 1995-05-05 | 2002-10-23 | 诺沃挪第克公司 | Pharmaceutical composition contg. tiagabine hydrochloride and process for its preparation |
WO2006062980A2 (en) * | 2004-12-07 | 2006-06-15 | Nektar Therapeutics | Stable non-crystalline formulation comprising tiagabine |
US8338621B2 (en) * | 2005-12-21 | 2012-12-25 | Ucb S.A. | Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
US8785661B2 (en) * | 2009-05-13 | 2014-07-22 | Nektar Therapeutics | Oligome-containing pyrrolidine compounds |
-
2013
- 2013-01-29 JP JP2015510893A patent/JP2015526385A/en active Pending
- 2013-01-29 CA CA2873016A patent/CA2873016A1/en not_active Abandoned
- 2013-01-29 WO PCT/IB2013/050740 patent/WO2013167986A2/en active Application Filing
- 2013-01-29 SG SG11201407309XA patent/SG11201407309XA/en unknown
- 2013-01-29 EP EP13787779.1A patent/EP2846795A2/en not_active Withdrawn
- 2013-01-29 AU AU2013257707A patent/AU2013257707A1/en not_active Abandoned
-
2014
- 2014-11-04 ZA ZA2014/08058A patent/ZA201408058B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2013257707A1 (en) | 2014-11-27 |
CA2873016A1 (en) | 2013-11-14 |
WO2013167986A2 (en) | 2013-11-14 |
WO2013167986A3 (en) | 2015-06-18 |
EP2846795A2 (en) | 2015-03-18 |
JP2015526385A (en) | 2015-09-10 |
SG11201407309XA (en) | 2014-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL266582A (en) | Compositions and methods for the treatment of hemoglobinopathies | |
HK1210957A1 (en) | Effluz inhibitor compositions and methods of treatment using the same | |
HK1214521A1 (en) | Compositions and methods for treating proteinopathies | |
EP2736528A4 (en) | Compositions and methods for the treatment of hiv | |
IL225239A0 (en) | Compositions for the treatment of acne and related disorders | |
IL238177A0 (en) | Methods and compositions for the treatment of cancer | |
EP2688594A4 (en) | Methods and compositions for the treatment of cancer | |
ZA201408056B (en) | Compositions and methods for the treatment of mucositis | |
DK3292875T3 (en) | Compositions and methods for treating diseases | |
IL239374A0 (en) | Compositions and methods for the treatment of brain cancers | |
HK1208598A1 (en) | Methods and compositions for treating pain | |
HK1206266A1 (en) | Methods and compositions for the prevention and treatment neuropathy | |
ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
ZA201408062B (en) | Compositions and methods for the treatment of multiple sclerosis | |
ZA201408060B (en) | Compositions and methods for the treatment of neurological disorders | |
ZA201408058B (en) | Compositions and methods for the treatment of epilepsy | |
ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
ZA201408061B (en) | Compositions and methods for the treatment of neurological disorders | |
EP2800763A4 (en) | Compositions and methods for treating multiple sclerosis | |
GB201221118D0 (en) | Methods of treatment | |
GB201216740D0 (en) | Methods of treatment | |
GB201216748D0 (en) | Methods of treatment | |
GB201206324D0 (en) | Methods of treatment | |
GB201206326D0 (en) | Methods of treatment | |
GB201206330D0 (en) | Methods of treatment |